Leap Therapeutics, Inc.

Leap Therapeutics, Inc.

LPTX
Leap Therapeutics, Inc.US flagNASDAQ Global Market
0.77
USD
-0.02
- -
31.86MMarket Cap

Leap Therapeutics, Inc. (LPTX) Stock Splits

Learn about Leap Therapeutics, Inc.'s most recent 1-for-10 basis stock split on June 21, 2023. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Leap Therapeutics, Inc.'s most recent stock split

Split Date: 2023-06-21
Split Ratio: 1:10
Price Before Split: $0.45
Price After Split: $0.04

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times fewer shares (a 1:10 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Leap Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-06-211:10Yes$0.45$0.04

About Leap Therapeutics, Inc.

Company overview and industry information

Leap Therapeutics, Inc. (LPTX) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Leap Therapeutics, Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.